Concourse Financial Group Securities’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-669
| Closed | -$98.2K | – | 5315 |
|
|
2024
Q4 | $98.2K | Buy |
669
+8
| +1% | +$1.17K | 0.01% | 947 |
|
|
2024
Q3 | $76.2K | Sell |
661
-8
| -1% | -$922 | ﹤0.01% | 1032 |
|
|
2024
Q2 | $92.1K | Buy |
669
+71
| +12% | +$9.78K | 0.01% | 954 |
|
|
2024
Q1 | $82.5K | Buy |
598
+47
| +9% | +$6.48K | 0.01% | 989 |
|
|
2023
Q4 | $72.6K | Buy |
551
+103
| +23% | +$13.6K | 0.01% | 998 |
|
|
2023
Q3 | $50.4K | Buy |
448
+150
| +50% | +$16.9K | ﹤0.01% | 1077 |
|
|
2023
Q2 | $28.1K | Sell |
298
-270
| -48% | -$25.5K | ﹤0.01% | 1329 |
|
|
2023
Q1 | $57.5K | Sell |
568
-8
| -1% | -$810 | ﹤0.01% | 1042 |
|
|
2022
Q4 | $68.8K | Sell |
576
-307
| -35% | -$36.7K | 0.01% | 952 |
|
|
2022
Q3 | $94K | Sell |
883
-400
| -31% | -$42.6K | 0.01% | 742 |
|
|
2022
Q2 | $125K | Sell |
1,283
-87
| -6% | -$8.48K | 0.01% | 732 |
|
|
2022
Q1 | $128K | Sell |
1,370
-204
| -13% | -$19.1K | 0.01% | 773 |
|
|
2021
Q4 | $134K | Buy |
1,574
+173
| +12% | +$14.7K | 0.01% | 880 |
|
|
2021
Q3 | $134K | Buy |
1,401
+455
| +48% | +$43.5K | 0.01% | 863 |
|
|
2021
Q2 | $92K | Buy |
946
+10
| +1% | +$973 | 0.01% | 1022 |
|
|
2021
Q1 | $91K | Buy |
936
+150
| +19% | +$14.6K | 0.01% | 982 |
|
|
2020
Q4 | $75K | Buy |
786
+121
| +18% | +$11.5K | 0.01% | 1004 |
|
|
2020
Q3 | $64K | Buy |
665
+377
| +131% | +$36.3K | 0.01% | 960 |
|
|
2020
Q2 | $35K | Buy |
288
+70
| +32% | +$8.51K | ﹤0.01% | 1099 |
|
|
2020
Q1 | $19K | Sell |
218
-60
| -22% | -$5.23K | ﹤0.01% | 1254 |
|
|
2019
Q4 | $30K | Buy |
278
+102
| +58% | +$11K | ﹤0.01% | 1128 |
|
|
2019
Q3 | $16K | Buy |
176
+24
| +16% | +$2.18K | ﹤0.01% | 1026 |
|
|
2019
Q2 | $13K | Sell |
152
-54
| -26% | -$4.62K | ﹤0.01% | 1405 |
|
|
2019
Q1 | $18K | Buy |
206
+72
| +54% | +$6.29K | ﹤0.01% | 1304 |
|
|
2018
Q4 | $9K | Buy |
134
+52
| +63% | +$3.49K | ﹤0.01% | 1458 |
|
|
2018
Q3 | $10K | Buy |
+82
| New | +$10K | ﹤0.01% | 1103 |
|